Terminologies
Macule:well-circumscribed, flat lesions that are
noticeable because of their change from normal skin
colour.
Papule: solid lesion raised above the skin surface
that are smaller than 1 cm in diameter.
Plaque:solid raised lesions that are over 1 cm in
diameter.
Nodule:lesions present deep in the dermis, and the
dermis can be easily moved over them.
Vesicle: elevated blisters containing clear fluid that
are under 1 cm in diameter.
Bullae:elevated blister like lesions containing clear
fluid that are over 1 cm in diameter
Erosion:moist red lesion often caused by the
rupture of vesicle or bullae as well as trauma.
Pustule:raised lesions containing purulent
material.
Ulcer: A defect in the epithelium; it is a well-
circumscribed depressed lesion over which the
epidermal layer has been lost.
Crust: accumulation on the skin of dried body
secretions like blood, pus or serum.
Scales:horny mass flaking from the outer part of
the skin.
Scar:morphological connective tissue replacement
of normal structures of skin or mucosa.
Autoimmune:failure of an organism to recognize
its own constituent parts as "self", which results in
an immune response against its own cells and
tissues.
Eczema:is broadly applied to a range of persistent
or recurring skin rashes characterized by redness,
skin edema, itching and dryness, with possible
crusting, flaking, blistering, cracking, oozing, or
bleeding.
Herpes simplex virus infections
Human herpes virus
Herpeto viridae
HSV1, HSV2
Other members
Natural reservoir & all HSVs have the ability to reside
within the infected host
Vesicular eruptions
two forms
systemic or primary & may be localized or secondary in
nature
HSV1, HSV2 & Varicella-Zoster
Cytomegalovirus –oral ulcerations, salivary gland
disease
4 layers
pathogenesis
Physical contact
Heparin sulphate, followed by the activation of specific
genes
Only a small % of individuals shows clinical signs &
symptoms
several days to 2 weeks
Primary lesions-vesicular eruption
After resolution, the virus migrate through unknown
mechanism to trigeminal ganglion
Reactivation -exposure to sunlight, to cold, trauma,
stress or immunosuppression
Travels by the way of trigeminl nerve to the originally
infected epithelial surface where replication occurs
The viruses returns to the trigeminal ganglion
Orofacial herpetic lesions
Primary herpes simplex virus infections
Children
Vesicular eruption
May appear on any mucosal surface
5-7 days, may range from 2-12 days
Generalized Prodromal symptoms
that precede the local lesions by 1-2 days
Small vesicles appear on oral mucosa; Thin walled small
vesicles
As the disease progress, several lesions may coalesce
forming larger irregular lesions
Gingiva –enlarged, painful & erythematous, acute
marginal gingivitis.
Posterior pharynx
After the systemic primary infection
runs its course of about 1 week to
10 days
Secondary or recurrent herpes simplex virus
Reactivation of latent virus
Up to 90% have antibodies to HSV & up to 40% of this
group
Prodromalsyndromes in the site in which lesions will
appear
Within a hours, multiple, fragile & short lived vesicles
appear
Unroofed & coalesce to form Map like superficial ulcers
Heal without scaring in 1-2 weeks rarely become
secondarily infected
Recurrence is variable
Decline with age with each individual
Typically occur at or near the same site
Herpes labialis
Hard palate & gingiva
1-3mm , with the size of cluster ranging from 1-2cm
Causing discomfort & disfigurement
Immune deficiency
Significant pain & discomfort as well as predisposition
to secondary bacterial & fungal infections
A typical, chronic or destructive.
Not site restricted
Larger lesions are more common
Herpetic whitlow
HSV infection involving the finger
Medical & dental personnel could infect their digits
Pain, redness & swelling
Vesicles or pustules
4 to 6weeks
Diagnosis
Usually made on clinical basis
Confirmation by laboratory methods
Expensive & time consuming
H/F
Intra epithelial blister filled with fluid
Swollen & have pale eosinophelic cytoplasm
Ballooning degeneration
Lipschutz bodies
Eosinophilic, ovoid, homogeneous structures within
the nucleus, chromatin peripherally
Vesicles containing exudates, inflammatory cells
Cytology
Giemsa, wright’sor papanicolaou’sstain
Multinucleated giant cells, syncytium& ballooning
degeneration of the nucleus
Fluorescent staining of cytology smears are has been
shown more senstive(83%) compared with routine
cytology (54%)
Multinucleated Giant cells
i
HSV Isolation
Isolation & neutralization of a virus in tissue culture is
the most +ve method of identification
Antibody titers
Testing for Complement –fixing or neutralizing
antibody in acute & convalescent sera
Rarely necessary in routine clinical situations
Management
Supportive treatment
Oral rehydration –Electrolytic Balance
Fever
Dyclonine hydrochloride 0.5%, if not available dypin
hydramine hydrochloride5mg/ml mixed with magnesia
Infants
Oral hygiene Maintenance
Chlorhexidine mouth wash
Curative Treatment
Timing is important
Acyclovir and its analogs
Inhibits DNA replication, decreases days of fever, pain,
lesions & viral shedding
Antiviral treatment
Axovir200mg 1-1-1-1-1 x 5 days
(Acyclovir)
Valacyclovir250mgtwice daily & Famciclovir250mg for
preventing genital recurrences
HIV +vepatients
Corticosteroids are CI
Preventive treatment
Patient should be isolated
If affected child has multiple siblings
Utensils should be kept separate
HSV vaccine
Live vaccines
Inactivated vaccines (Lupidon)
Nucleic acid based vaccines(DNA vaccine)
HSV vaccines
Should be given early in life
Prevent productive infection does not prevent latent infection
Importantly, recent epidemiological data indicate that HSV
infection increases the rate of HIV transmission twofold.
Current Herpes Simplex Virus Vaccine Approaches—A Short Reviewa report
byE l i z a b e t h E B r i t t l e and Har vey M Friedman Division of Infectious
Diseases, University of Pennsylvania
Herpvac vaccine
Preventing HSV-2 infection
The vaccine has only been shown to be effective for women
who have never been exposed to HSV-1.
BioVex, are involved in immune evasion and reduction of
immunogenicity
Current Herpes Simplex Virus Vaccine Approaches—A Short Reviewa
report byE l i z a b e t h E B r i t t l e and Har vey M Friedman
Division of Infectious Diseases, University of Pennsylvania
Varicella-zoster infection
Varicella or chicken pox
Herpes zoster or shingles
Pathogenesis
The inhalation of contaminated droplets
Contagious
Virus proliferates within macrophages, with subsequent
viremia & dissemination to the skin & other organs
Host defense mechanisms of nonspecific interferon
production
As the viremia overwhelms body defenses, systemic signs &
symptoms develop
Primary diseases or chicken pox
Self limiting, common in children
Vesicular eruption (in crops)
Fever, malaise, pharyngitis & rhinitis etc
Face & trunk, followed by involvement of extremities
Erythema, vesicles, pustules & hardened crust
Early vesicular stage
Surrounded by a zone of erythema & has been described
as “ a due drop on a rose petal.”
Contagious
Oral lesions are fairly common & may precede the skin
lesions
Most frequently involve sites
Occasionally there are gingival lesions
Complications
More frequent in in adult patient
Pnemonitis, encephalitis & inflammation of other organs
Fetal abnormalities may occur
Typically Ataxia but may result in head aches, drowsiness,
convulsions or coma
Dry cough & chest pain
Congenital or neonatal chicken pox
Spontaneous abortion or congenital defects
H/F
Identical to HSV
Acantholysis , with formation of numerous free-floating
Tzanck cells, which exhibit nuclear margination of
chromatin & occasional multinucleation
D/D
HSV
Herpengina
HFM disease
Diagnosis
History of exposure & by the type & distribution of lesions
Cytologic changes are identical HSV.
Virus antigen typing using laboratory immunologic tests (
eg ; immunohistochemistry or DNA in situ hybridization)
Treatment & prognosis
Supportive therapy
In immunocompromised patients more substantial
measures are warranted
Virus –specific drugs
Acyclovir, vidarabine & human leukcyte interferon
Herpes zoster
Older adult population & who have compromised immune
responses
Transported to sensory nerves & establish latency in dorsal
spinal ganglia
Occurs after reactivation of virus
Uncommon, immunosuppressive states,
drug administration or HIV infection.
Radiation or surgery of spinal cord or local trauma
Prodromal symptoms
Vesicular skin eruption
Lasts several weeks & may be followed by post herpetic
neuralgia, local hyper pigmentation
The sensory nerves are commonly effected
Unilateral oral facial or ocular lesions
Ramsay hunt syndrome
Prodromal pain is present 1 to 4 days before the
development of cutaneous or oral lesions
Cluster of vesicles with erythematous base within 3-4days
vesicles beome pustular & ulcerate with crust developing
after 7-10 days
Scarring is not un common
Follow the path of the affected nerve & terminate at the
midline
Post herpeuticneuralgia
Ocular involvement is usual
Oral lesions occur with trigeminal nerve involvement
Lesion often extend the midline
Individual lesion present as 1-4mm white opaque vesicles
Involvement of maxilla
Significant bone necrosis with loss of teeth
H/F
Microscopically identical to those seen in primary
infections varicella
D/D
Recurrent HSV infections
HFM disease
Diagnosis
Viral cultures
Cytologic smears demonstrate viral cytopatologic effects
Use of direct staining of cytologic smears with fluorescent
monoclonal antibodies for VZV
```````````````
Treatment
Shortening the course of the disease, preventing
posttherepetic neuralgia & preventing dissemination
Acyclovir or newer anti herpes drugs accelerate healing &
reduce acute pain
Effective therapy includes application of capsaicin
Topical capsaicin
Tricyclic antidepressant or gaba pentin
Chemical or surgical neurolysis may be necessary in
refractory cases
Oral corticosteroids provide symptomatic relief but do not
reduce the risk of post herpetic neuralgia
Varicella –zoster vaccines
There are two types of varicella vaccines:
chickenpox vaccine
shingles vaccine
[A vaccine (Proquad) for children ages 1 -12 years now
combines measles, mumps, rubella, and varicella in one
product.]
Recommendations for the Chickenpox Vaccine in Adults
Those with high risk of exposure or transmission
People in contact with those who have compromised immune
systems
Nonpregnant women of childbearing age
International travellers
Shingles Vaccine
The zoster vaccine (Zostavax) is a stronger version of the
chickenpox vaccine
Varicella-Zoster Immune Globulin
Pregnant women
Newborn infants
Premature infants
Immunocompromised children and adults with no
antibodies to VZV
bone-marrow transplants
debilitating disease
Hand –foot –and-mouth disease
Picorna virus is the coxsackie group
Certain coxsackie subtypes cause oral vesicular eruptions:
Highly contagious, coxsackie type A16 less frequently by
types A5, A6 & occasionally even by B2, B5 or entero virus 71
Air born spread or fecal-oral contamination with subsequent
viremia
Common sites
C/F
Young children
Mucopapular, exanthematous & vesicular lesions of the
skin
Hands, feet, legs, arms etc
Common manifestations
O/M
A sore mouth & refusal to eat
Small, multiple vesicles & ulcerative oral lesions
Hard palate, tongue & buccal mucosa
Lips, gingiva & pharynx including the tonsils
Vesicular state & eventually become ulcerated & encrusted
Laboratory findings
Intra cytoplasmic viral inclusions
In addition, viral isolates may usually be obtained from
throat swabs from vesicular fluid it self
Remarkable rise in acute or convalescent serum antibody
titer to coxsackie A16
D/D
Primary herpetic gingivostomatitis
Varicella
Treatment
Symptomatic treatment, bland mouth rinses such as
sodium bicarbonate in warm water
Foot & mouth disease
( Apthous fever, hoof –and –mouth disease, epizootic -
stomatitis)
Rarely affects man
Contact with infected animals
C/F
Fever, nausea, vomiting, malaise & appearance of ulcerative
lesions
Vesicles on the skin also occurs in some cases, most
commonly on the palm & soles
O/M
Any site, more chiefly affected areas
Begin as small vesicles, which rapidly rupture, but heal
usually within two weeks
D/D
HFMD
Treatment
Herpangina
(Apthous pharyngitis, vesicular pharyngitis )
Another coxsackietype A( type A1-6 , A8,A10, A22,B3 & possibly
others)
Contaminated saliva
C/F
Frequently occurs in sporadic outbreaks
2-10 days
Young children
Chiefly a summer disease
Comparatively mild & of short duration
Sore throat, cough, rhinorhea, low grade fever, headache,
sometimes vomiting, abdominal pain
Vesicles ,rupture to form crops of ulcers
Grey base & inflamed periphery
Vesicles preceding the ulcers are small & of short duration
Not extremely painful
Heal within 7-10 days
Small pox ( variola)
Was epidemic in nature & accounted for literally millions
of death
C/F
After incubation period, manifests high fever, nausea,
vomiting, chills & headache
Skin lesions first appear on the face, but rapidly spread to
cover much of the body surface
Papule –vesicles –pustule
Small, elevated, & yellowish green with an inflamed border
Secondarily infected
O/M
Ulceration
Multiple vesicles
Tongue swollen & painful
D/D
Chicken pox
Drug eruptions
Complications
Secondary infections. Abscesses formation, septicemia , as
well as respiratory infection & infections of eye & ear
Comparison b/w vesicular viral lesions
Disease Area involved prodroml
symptoms
Incubation Treatment
Primary herpes
virus infection
Face ,lips,
gingivitis,
upper body
skin
precede local
lesions by 1-2
days
5-7days,
ranging from2-
12days
Self limiting
heal within1
week
Secondary
herpes
infection
Perioral skin,
lips, gingiva
,palate
Pain ,tingling,
burning
precede lesion
by 1hr
Possible control
with Acyclovir
Varicella Head ,trunk ,
face& neck in
crops
Fever , malaise,
pharyngitis &
rhinitis
2 weeks symptomatic
Herpes zosterUnilateral
distribution
Pain &
paresthesia of
involved nerve
site
Anti herpes
drugs, useof
corticosteroid
is controversial
Comparison b/w vesicular viral lesions
Hand foot
mouth disease
Hands,feet ,
legs, arms
Anorexia , low
grade fever,
coryza,
diarrhea,
lymphdenopat
hy
Symptomatic
Hoof & mouth
disease
Lips, tongue,
palate,
oropharynx&
skin in some
cases
Fever, nausea,
vomiting &
malaise
Self limiting
Herpangina Anterior faucial
pillars,
sometimes on
hard palate
Sore throat,
cough
rhinohorhea,
abdominal pain
2-10 days Not required
Small pox Oral mucosa&
pharynx
trachea,
esophagus ete
Fever ,nausea
vomiting ,chills
& head ache
7-10 days Self limiting
END OF PART 1
REFERENCES
Differential diagnosis of oral & maxillofacial
lesions, NORMAN K WOOD & PAUL W . GOAZ
Burket’s oral medicine (10
th
addition )
Oral and maxilofacialpathology (Neville, Damm, Allen)
Text book of dermatology by Rook, Wilkinson,Ebling
Oral pathology by J.V Soames, J.C.Southam
Shafer’s text book of oral pathology (5
th
adition)
Oral pathology by Regezi& Scuiubba